TDSGF (Telo Genomics) Common Stock: $17.95 Mil (As of Mar. 2026)


What is Telo Genomics Common Stock?

Telo Genomics TDSGF Common Stock is $17.95 Mil as of Mar. 2026. The stock has 2 warning signs investors should review.

Telo Genomics's quarterly common stock increased from Sep. 2025 ($17.80 Mil) to Dec. 2025 ($17.85 Mil) and increased from Dec. 2025 ($17.85 Mil) to Mar. 2026 ($17.95 Mil).

Telo Genomics's annual common stock declined from Jun. 2023 ($16.32 Mil) to Jun. 2024 ($16.31 Mil) but then increased from Jun. 2024 ($16.31 Mil) to Jun. 2025 ($17.98 Mil).

Telo Genomics Common Stock Historical Data

* Premium members only.

The historical data trend for Telo Genomics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Telo Genomics Common Stock Chart

Telo Genomics Annual Data
Trend Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.92 14.92 16.32 16.31 17.98

Telo Genomics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.12 17.98 17.80 17.85 17.95

Telo Genomics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $17.95 Mil mean?
Telo Genomics (TDSGF) has a Common Stock of $17.95 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Telo Genomics and its competitors.
Is Telo Genomics' Common Stock too high?
Telo Genomics' current Common Stock is $17.95 Mil.
How does Telo Genomics' Common Stock compare to TMO and DHR?
Telo Genomics' Common Stock of $17.95 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Telo Genomics and its competitors. Telo Genomics's current Common Stock is $17.95 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telo Genomics stock overvalued right now?
Telo Genomics (TDSGF) has a current Common Stock of $17.95 Mil. The current Common Stock is $17.95 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Telo Genomics (TDSGF), the current Common Stock is $17.95 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Telo Genomics Business Description

Other Exchanges 3D0A:GermanyTELO:Canada
Address 2255 York Avenue, Suite 203, Vancouver, BC, CAN, V6K 1C5
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability. The company has a single operating segment, focused on the development and commercialization of predictive technological products designed to personalize treatment plans for patients who have specific conditions.